TOP

News

Arkis BioSciences® opens state-of-the-art facility at Cherokee Farm Innovation Campus

Arkis BIoSciences was proud to announce our Grand Opening this morning at the Cherokee Farm Innovation Campus, a new high-tech facility at the University of Tennessee's research and development campus.

View the full press release

 

Arkis BioSciences® is launching the new CerebroFlo™ EVD Catheter with Endexo® Technology at the 2017 Congress of Neurological Surgeons

Arkis BioSciences is launching the CerebroFlo™ EVD Catheter with Endexo® Technology at the 2017 Congress of Neurological Surgeons, booth 747. Demonstrations are available at the booth for the Single Pass Tunneling Guidewire®, the Subcutaneous Guidewire™, and the CerebroFlo EVD Catheter.

Interface Biologics Enters the Neurology Market with 510(k) Clearance of Arkis BioSciences® CerebroFlo™ EVD Catheter with Endexo® Technology

Interface Biologics Inc. ("IBI"), a privately held, commercial stage company developing innovative material science technologies that save lives and improve patient outcomes, is pleased to announce that Arkis BioSciences® has received 510(k) clearance from U.S. Food and Drug Administration (FDA) for its exclusive CerebroFlo™ EVD Catheter with IBI's Endexo® technology.

View the full press release

 

Arkis BioSciences® achieves FDA clearance of its new CerebroFlo™ EVD Catheter with Endexo® Technology

Arkis BioSciences, a leading innovator in minimally invasive surgical instrumentation, has obtained FDA clearance of its new external ventricular drainage catheter, CerebroFlo™.  The CerebroFlo catheter has demonstrated a 99% reduction in thrombus accumulation in-vitro, and is indicated for temporary use in patients with elevated intracranial pressure, intraventricular hemorrhage, or hydrocephalic shunt infections. Arkis will debut the CerebroFlo EVD Catheter at the upcoming Congress of Neurological Surgeons (booth 747), in Boston MA, October 7-11, 2017.

View the full press release

Arkis BioSciences selected as a Top Innovator at the 2017 New York Venture Summit
Arkis is honored to have been chosen as a Top Innovator at the 2017 NY Venture Summit, July 18-19th, 2017.  Be sure to visit us in the Big Apple and learn the latest news as Arkis continues to roll out its product portfolio advancing treatments for intracranial hypertension.   
 

Read More

Arkis showcases new Subcutaneous Guidewire at the Los Angeles AANS Conference, April 24-26th at booth 2047.

Arkis BioSciences exhibits new Subcutaneous GuidewireTM, adding to its minimally invasive product line.

Please visit the team now at booth 2047 of the AANS conference in Los Angeles to see the latest additions to the surgical portfolio, and receive an update on our new SureFloTM EVD catheters with Endexo® technology.

Download full press release

Arkis BioSciences Expands Clinical Use Of Its New Minimally Invasive Tunneling Guidewire™ Technology.

Single PassTM shunt workflow enables up to one-third less invasive shunt procedures in hydrocephalus patients.  Please see the full press release, or view our Surgical Innovations product site for more information on our minimally invasive Tunneling GuidewireTM.  

View the full press release

 

Arkis BioSciences exhibits at the 2016 AANS/CNS Joint Section of Pediatric Surgery

Arkis BioSciences will be exhibiting at Booth 210 of the 45th annual AANS/CNS Joint Section of Pediatric Sugery, December 5th-8th 2016 in Orlando, FL.  Our innovative product portfolio of neurosurgical devices including our Tunneling Guidewire, Precision Tunnelerand Subcutaneous Guidewirewill be available for demonstration.  We will also be sharing the company's plans for the launch of Endexo External Ventricular Drainage catheters.  For more information, please visit pedsneurosurgery.org/meetings/current-meeting/.

Read More

Arkis BioSciences exhibits at the 2016 Congress of Neurological Surgeons

Arkis BioSciences will be exhibiting at the 2016 Congress of Neurological Surgeons in San Diego, September 24th - 28th.  Our innovative product portfolio of neurosurgical devices, including our Tunneling Guidewire, will be available for demonstration.  We will also be sharing the company's plans for the launch of Endexo External Ventricular Drainage catheters.  For more information, please visit the 2016 CNS website at www.cns.org/annual-meeting-2016.

Read More

Arkis BioSciences a Bronze Sponsor of the 2016 Nashville Hydrocephalus Association Walk

Come see us at the Nashville Hydrocephalus Association Walk, where people join together to promote a cure for hydrocephalus and to improve the lives of those affected by hydrocephalus!  With only 9 days left, the Nashville HA teams have already raised over $17,000 dollars!  Arkis BioSciences is proud to be a Bronze sponsor of this year's Nashville HA walk.  For more information, visit the Nashville HA Walk team page.

Read More

Pages

 

Contact Us

Address:  P.O. Box 9815, 1 Momentum Way, Knoxville, TN 37920   |    Tel: (844) 247-5383 (toll free)

 © Arkis Biosciences   |    Privacy   |    Sitemap

 

 
Go to top